News
News

The latest updates from AFAR.

Board Member in the News: Nir Barzilai in Medium on the Targeting Aging with Metformin (TAME) Trial

Sep 10
2018

Board Member in the News: Nir Barzilai in Medium on the Targeting Aging with Metformin (TAME) Trial View MoreBACK

On September 5, 2018, Medium shared the insights of AFAR expert Nir Barzilai,  M.D. and highlighted the AFAR-managed Targeting Aging with Metformin (TAME) Trial.

Dr. Barzilai is AFAR’s Deputy Scientific Director as well as a 1997 Beeson Scholar and 1994 AFAR Research Grant recipient.

Read  “The Safe, Boring, and Extremely Cheap Drug That Could Cure Aging” here.





View MoreBACK TO TOP